Alzheimer Disease
Showing NaN - NaN of 49
Alzheimer Trial in Canada, United States (Placebo Control, ELND005)
Alzheimer, Alzheimer, Late Onset Trial in Tampa (MemorEM 1000)
Completed
- Alzheimer Disease
- Alzheimer Disease, Late Onset
- MemorEM 1000
-
Tampa, FloridaByrd Alzheimer's Institute, University of South Florida
Apr 22, 2019
Alzheimer, Cognition Disorders Trial in United States (florbetapir F 18 PET scan)
Completed
- Alzheimer Disease
- Cognition Disorders
- florbetapir F 18 PET scan
-
Glendale, Arizona
- +74 more
Oct 23, 2018
Alzheimer Trial in United States (Naproxen Sodium (Aleve), Celecoxib (Celebrex))
Completed
- Alzheimer Disease
- Naproxen Sodium (Aleve)
- Celecoxib (Celebrex)
-
Sun City, Arizona
- +5 more
Oct 18, 2016
Alzheimer Trial in Worldwide (bapineuzumab, )
Alzheimer Trial in Worldwide (Florbetaben (BAY94-9172))
Completed
- Alzheimer Disease
- Florbetaben (BAY94-9172)
-
Sun City, Arizona
- +18 more
Apr 27, 2016
Alzheimer Trial in Worldwide (bapineuzumab, )
Alzheimer Trial in Worldwide (Bapineuzumab 0.5 mg/kg)
Terminated
- Alzheimer Disease
- Bapineuzumab 0.5 mg/kg
-
Birmingham, Alabama
- +182 more
Nov 30, 2015
Alzheimer Trial in Canada, United States (NS 2330 (Tesofensine))
Completed
- Alzheimer Disease
- NS 2330 (Tesofensine)
-
Mesa, Arizona
- +86 more
Oct 28, 2013
Down Syndrome, Alzheimer Trial in Worldwide (Vitamin E, multivitamin, Placebo)
Unknown status
- Down Syndrome
- Alzheimer Disease
- Vitamin E
- +2 more
-
Farmington, Connecticut
- +21 more
May 2, 2012
Alzheimer Trial in Canada, United States (xaliproden (SR57746A))
Completed
- Alzheimer Disease
- xaliproden (SR57746A)
-
Birmingham, Alabama
- +120 more
Aug 20, 2008
Alzheimer Trial in United States (Huperzine A)
Completed
- Alzheimer Disease
- Huperzine A
-
Birmingham, Alabama
- +28 more
Feb 19, 2008
Healthy Aging and Memory Study
Completed
- Alzheimer Disease
-
Birmingham, Alabama
- +38 more
Sep 14, 2007